Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04938245 · ClinicalTrials.gov registry record

Improving Spinal Cord Stimulation With ECAPS

A clinical trial of Chronic Pain, sponsored by University of Minnesota.

Recruiting
Registry status
15
Enrollment target
1
Study location

NCT04938245: Recruiting study of Chronic Pain, sponsored by University of Minnesota.

NCT04938245 is a study of Chronic Pain that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 15 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04938245, a study of Chronic Pain, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study will be to investigate the optimization of spinal cord stimulation with ECAPs in patients with spinal cord implants.

Primary Outcome

Feasibility will be measured as a number of the number of enrolled participants who complete at least 80% of the planned assessments.

Conditions Studied

Interventions

  • DEVICE Spinal Cord Stimulation

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-08-18
Est. Completion 2026-12-31
University of Minnesota

966 total trials

What NCT04938245 shows while recruiting

NCT04938245 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Spinal Cord Stimulation is the first listed.

NCT04938245 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT04938245 about?

NCT04938245 is a clinical study titled "Improving Spinal Cord Stimulation With ECAPS". The purpose of this study will be to investigate the optimization of spinal cord stimulation with ECAPs in patients with spinal cord implants.

What is the current status of trial NCT04938245?

This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2021-08-18. Estimated completion is 2026-12-31.

What conditions does trial NCT04938245 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT04938245?

The interventions under investigation include: Spinal Cord Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04938245?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04938245 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04938245's enrollment target sits among peer trials

15 281st of 301 higher than 18 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04938245, the US trial registry maintained by the National Library of Medicine. NCT04938245 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.